Home > NRC Library > ADAMS Public Documents

Amend 33 to License 12-18044-01MD for Nuclear Pharmacy,Inc, revising Items 6,7,8 & 9 re licensed matls,Conditions 12 & 24 on possession & use of matls & adding Condition 26 extending expiration date.

Accession Number: ML20135H711

Date Released: Monday, October 28, 2024

Package Contents

The following links on this page are to Adobe Portable Document Format (PDF) files. To obtain a free viewer for displaying this format, see our Plugins, Viewers, and Other Tools.

• ML20135H714 - Forwards Amend 33 to License 12-18044-01MD. (2 page(s), 9/5/1985)
• ML20135H720 - Application for amend to License 12-18044-01MD,increasing max amount of listed radioactive matl for possession at any one time & authorizing use of any byproduct matl listed in 10CFR31.11(a) in in vitro diagnostic kits. (19 page(s), 7/18/1985)